MOTS-c
EXTENSIVELY STUDIEDMitochondrial open reading frame of the 12S rRNA-c
Overview
What is MOTS-c?
MOTS-c is a 16-amino-acid mitochondria-derived peptide encoded by the mitochondrial genome. It acts as a mitohormone that regulates metabolic homeostasis, improves insulin sensitivity and promotes longevity. It works through the folate-AICAR-AMPK pathway.
Key benefits
Greater insulin sensitivity, better glucose metabolism, AMPK pathway activation, mitochondrial function optimization, improved physical performance and possible longevity benefits.
Mechanism of action
MOTS-c works through the folate-AICAR-AMPK pathway, inhibiting the folate cycle and activating AMPK. Under metabolic stress, it moves to the nucleus and binds stress-response transcription factors to regulate genes involved in metabolism, antioxidant response and cellular stress adaptation.
Quick start guide
What to expect
- Week 1-2: AMPK pathway activation and first improvements in glucose tolerance.
- Week 2-4: greater exercise capacity and better insulin sensitivity.
- Week 4-8: sustained metabolic benefits and possible body composition improvements.
- Week 8-12: maximum mitochondrial function improvement and metabolic flexibility.
- Side effects: generally mild, possible injection-site reactions.
Side effects & safety
- Generally well tolerated in animal studies, with minimal side effects.
- Monitor blood glucose if you take diabetes medication: it may require dose adjustments.
- Long-term human safety data are limited: use with appropriate medical supervision.
- May cause mild injection-site reactions (redness, swelling).
- Not recommended during pregnancy or breastfeeding.
- Banned by WADA for competitive athletes (metabolic modulator).
- Allergic reaction: rash, itching or swelling.
- Hypoglycemia episodes (low blood sugar): tremors, sweating or confusion, especially if you take diabetes medication.
- Signs of infection at the injection site: redness, warmth, pus or intense pain.
- Extreme fatigue or persistent malaise.
- If you are pregnant, breastfeeding or planning a pregnancy.
Frequently asked questions
What is MOTS-c?
MOTS-c is a 16-amino-acid mitochondria-derived peptide that acts as a metabolism-regulating mitohormone.
What is MOTS-c researched for?
It is studied for metabolism and glucose, insulin sensitivity, physical performance and longevity.
How does MOTS-c work?
It works through the folate-AICAR-AMPK pathway and, under metabolic stress, regulates genes related to metabolism and antioxidant response.
How long does MOTS-c take to work?
AMPK activation occurs within minutes; glucose improvements are described in 1-2 weeks and full benefits in 4-8 weeks.
What is the usual MOTS-c dose?
Most commonly 5-15 mg, daily or 3 times a week. The schedule should be assessed by a professional.
How is MOTS-c administered?
Subcutaneously (abdomen, thigh or arm), preferably in the morning or before exercise.
How is MOTS-c stored?
The lyophilized powder at room temperature or freezer and, reconstituted, refrigerated. See the storage guide.
What are the side effects of MOTS-c?
It is described as well tolerated in animal studies; long-term human safety data are limited.
Which peptides is MOTS-c combined with?
It is usually paired with peptides aimed at metabolism or longevity, depending on the goal.
Is MOTS-c approved?
It is not approved and is banned by WADA as a metabolic modulator.
What is the difference between MOTS-c and GLP-1 peptides?
MOTS-c acts on the mitochondria and the AMPK pathway, not on appetite like GLP-1 agonists.
Research areas
- Metabolism and glucose
- Insulin sensitivity
- Physical performance
- Mitochondrial function
- Longevity
Related peptides
- Epitalon — Pineal tetrapeptide associated with longevity.
- AOD-9604 — hGH fragment researched for fat loss.
- Semaglutide — GLP-1 receptor agonist for weight and diabetes.
Related articles
Related topics
- MOTS-c and metabolism
- MOTS-c and endurance
- MOTS-c dose
- MOTS-c and longevity
- MOTS-c and insulin sensitivity
- MOTS-c mitochondrial peptide
Summary
What it is: 16-amino-acid mitochondrial peptide (mitohormone).
How it is researched: 5-15 mg, daily or 3 times a week, subcutaneous.
Key features: Acts through the AMPK pathway; associated with metabolism and longevity. Not approved and banned by WADA.
Related peptides: Epitalon, AOD-9604 and Semaglutide.